Risk of diabetic retinopathy and diabetic macular oedema with sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists in type 2 diabetes: a real-world data study from a global federated database.
Eleftheriadou A, Riley D, Zhao SS, Austin P, Hernández G, Lip GYH, Jackson TL, Wilding JPH, Alam U.
Diabetologia. 2024 Jul;67(7):1271-1282. doi: 10.1007/s00125-024-06132-5. Epub 2024 Apr 8.
Thirty-Year Time Trends in Diabetic Retinopathy and Macular Edema in Youth With Type 1 Diabetes.
Allen DW, Liew G, Cho YH, Pryke A, Cusumano J, Hing S, Chan AK, Craig ME, Donaghue KC.
Diabetes Care. 2022 Oct 1;45(10):2247-2254. doi: 10.2337/dc21-1652.
Development and validation of a simple and practical model for early detection of diabetic macular edema in patients with type 2 diabetes mellitus using easily accessible systemic variables.
Wu G, Hu Y, Zhu Q, Liang A, Du Z, Zheng C, Liang Y, Zheng Y, Hu Y, Kong L, Liang Y, Amadou MLDJ, Fang Y, Liu Y, Feng S, Yuan L, Cao D, Lin J, Yu H.
J Transl Med. 2024 May 31;22(1):523. doi: 10.1186/s12967-024-05328-y.
Homocysteine is linked to macular edema in type 2 diabetes.
Li J, Zhang H, Shi M, Yan L, Xie M.
Curr Eye Res. 2014 Jul;39(7):730-5. doi: 10.3109/02713683.2013.877933. Epub 2014 Feb 6.
ELEVATED LEVEL OF URIC ACID, BUT NOT GLUCOSE, IN AQUEOUS HUMOR AS A RISK FACTOR FOR DIABETIC MACULAR EDEMA IN PATIENTS WITH TYPE 2 DIABETES.
Qin YJ, Zhang YL, Zhang YQ, He BT, Wang S, Yu HH, Chan SO, Zhang HY.
Retina. 2022 Jun 1;42(6):1121-1129. doi: 10.1097/IAE.0000000000003424.
Pre-therapeutic Biomarkers for Ranibizumab Therapy among Type 2 Diabetic Patients with Diabetic Macular Edema.
Paine SK, Bhattacharjee CK, Bhaduri G, Pramanik S, Borah PK, Mahanta J, Basu A, Mondal LK.
Optom Vis Sci. 2021 Jan 1;98(1):81-87. doi: 10.1097/OPX.0000000000001622.
Association Between Obstructive Sleep Apnea and Diabetic Macular Edema in Patients with Type 2 Diabetes.
Chiang JF, Sun MH, Chen KJ, Wu WC, Lai CC, Chang CJ, Lin YJ, Chang SC, Huang HY, Chen NH, Li HY.
Am J Ophthalmol. 2021 Jun;226:217-225. doi: 10.1016/j.ajo.2021.01.022. Epub 2021 Jan 30.
Serum apolipoprotein A1 and B are associated with 6-month persistent and incident diabetic macular oedema in type 2 diabetes.
Soedarman S, Julia M, Gondhowiardjo TD, Prasetya ADB, Kurnia KH, Sasongko MB.
BMJ Open Ophthalmol. 2023 Jun;8(1):e001207. doi: 10.1136/bmjophth-2022-001207. Epub 2023 Jun 27.
Proteinuria in early referral to spectral domain optical coherence tomography for macular edema detection in type 2 diabetes individuals: results from the Brazilian diabetes study.
Barreto J, Chaves F, Fernandes VHR, Jesus DC, Nascimento MA, Lira RPC, Nadruz W, Arieta C, Sposito AC.
Curr Med Res Opin. 2022 Dec;38(12):2141-2148. doi: 10.1080/03007995.2022.2131302. Epub 2022 Nov 4.
Higher levels of circulating ANGPTL2 are associated with macular edema in patients with type 2 diabetes.
Yin R, Zhang N, Zhang D, Zhao W, Ke J, Zhao D.
Medicine (Baltimore). 2021 Feb 12;100(6):e24638. doi: 10.1097/MD.0000000000024638.
